WILLIAMS AND JENSEN, PLLC for PFIZER
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 19, 2016 | $80,000 | Replaced |
| 4th Quarter - Amendment | Jul 6, 2016 | $80,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trade issues related to Trade Promotion Authority legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
Medicare/Medicaid MMM
Medicare payment issues including the Independent Payment Advisory Board (IPAB) and Medicaid issues. Medicare Part D. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015. H.R. 2029.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANE DOUCET | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| CHERYL LYNN JAEGER | — |
| ANDREW JONES | Legislative Counsel, Rep. Hinojosa; Legislative Director and Counsel, Rep Lujan |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Taxation/Internal Revenue Code TAX
Tax issues affecting the pharmaceutical industry including international tax. Revenue proposals on international tax. Comprehensive tax reform proposals. H.R. 2029, Division Q.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DENIS DWYER | — |
| CHRISTOPHER W HATCHER | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Health Issues HCR
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Rebates for Medicare Part D; Federal preemption for prescription drugs; drug importation; and drug shortages; track and trace; 21st Century Cures Initiative. H.R. 2029
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANE DOUCET | — |
| DENIS DWYER | — |
| JACK STEVEN HART | — |
| CHRISTOPHER W HATCHER | — |
| SUSAN HATCHER | — |
| MATTHEW B HOEKSTRA | — |
| CHERYL LYNN JAEGER | — |
| ANDREW JONES | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
| JOEL OSWALD | — |
| ANTHONY J RODA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.